Use Reciprocal Public License or new license

[Fearn, Paul A./Urology]

After reviewing the existing approved licenses, our
team thought the Reciprocal Public License 1.1 meets
our needs, however our industrial affairs team wanted
to make some small changes. 

Could you let me know if these 4 changes are reasonable,
or if we need to go through the new license approval
process?

Thanks,
Paul Fearn
------------------------------------

Reciprocal Public License 
Version 1.1, November 1, 2002 

-------------------------------------
1. Does the copyright statement at top of license need to 
stay as

"Copyright (C) 2001-2002 
Technical Pursuit Inc., 
All Rights Reserved."

or should it be changed to this?

"Copyright (C) 2004 
Caisis Team, Memorial Sloan-Kettering Cancer Center,
All Rights Reserved."

------------------------------------

2. In Preamble paragraph 2, our industrial affairs team wanted
to add the "including Licensor" phrase after "third parties"?
Would this require creating a new license?

"This License is based on the concept of reciprocity. In exchange for
being granted certain rights under the terms of this License to
Licensor's Software, whose Source Code You have access to, You are
required to reciprocate by providing equal access and rights to all
third parties [including Licensor] to the Source Code of any
Modifications, Derivative Works, and Required Components for execution
of same (collectively defined as Extensions) that You Deploy by
Deploying Your Extensions under the terms of this License. In this
fashion the available Source Code related to the original Licensed
Software is enlarged for the benefit of everyone.

-------------------------------------- 

3. In Preamble item c from this section
"Under the terms of this License You may:," the group also
wanted to add the "including Licensor" phrase.

"c. Create Extensions to the Licensed Software consistent with the
rights granted by this License, provided that You make the Source Code
to any Extensions You Deploy available to all third parties [including
Licensor], under the terms of this License, document Your Modifications
clearly, and title all Extensions distinctly from the Licensed
Software." 

--------------------------------------
4. Are these changes to Exhibit A correct?

Copyright (C) 1999-2004  P.Alli,  J.Fajardo,  P.Fearn, D.Kuo, K.Regan,
F.Sculli ("Caisis Team"), Memorial Sloan-Kettering Cancer Center,  All
Rights Reserved. 

Unless explicitly acquired and licensed from Licensor under the MSKCC
Software Transer Agreement("STA"), the contents of this file are subject
to  the Reciprocal Public License ("RPL") Version 1.1, or subsequent
versions as allowed by the RPL, and You may not copy or use this file in
either  source code or executable form, except in compliance with the
terms and conditions of the RPL. 

You may obtain a copy of both the STA and the RPL (the "Licenses") at
http://www.cancerdb.org.





 
     =====================================================================
     
     Please note that this e-mail and any files transmitted with it may be 
     privileged, confidential, and protected from disclosure under 
     applicable law. If the reader of this message is not the intended 
     recipient, or an employee or agent responsible for delivering this 
     message to the intended recipient, you are hereby notified that any 
     reading, dissemination, distribution, copying, or other use of this 
     communication or any of its attachments is strictly prohibited.  If 
     you have received this communication in error, please notify the 
     sender immediately by replying to this message and deleting this 
     message, any attachments, and all copies and backups from your 
     computer.

--
license-discuss archive is at http://crynwr.com/cgi-bin/ezmlm-cgi?3